STANTEC INC. (STN): what the price assumes

In the published model solve dated 2026-Q2, anchored at $74.21, STANTEC INC. (STN) is priced for +6.1% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-19.

Generated: 2026-08-25 · Source: https://boothcheck.com/report/STN

Headline

FieldValue
TickerSTN
CompanySTANTEC INC.
Sector / IndustryIndustrials
Current price$74.21/sh
CompositionInfrastructure 26% / Water 21% / Buildings 24% / Environmental Services 19% / Energy & Resources 10%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)1.7%
Operating margin today9.1%
Margin compression (value-band)-7.4pp
Implied growth6.1%
Multiple paid19x operating income

The operating-margin figure is value-band context at year 10: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.1% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: n/a

ReferenceValue
vs own history-0.64σ

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.86x4expensive
Earnings1.58x3expensive
Relative0.84x4justifies
Growth0.70x2justifies

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.3%); the inversion above states its own rate.

Per-Model Detail (n=13)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$181.830.41xyesFCF base $0.7B, growth 16% (input: historical growth), terminal g 4.0%, WACC 8.3%, 6yr projection
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$64.261.15xyesP/E 18x (static sector reference · 2026-04), scenarios: 14.8x / 18.0x / 21.2x (bear / base = reference held flat / bull), EV/EBITDA 12x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$33.412.22xyesBV/sh $20.89, ROE (TTM) 14.8%, ke 9.3%
Two-Stage Excess ReturnAsset$41.761.78xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$74.341.00xyesRev $6.0B, growth 16% (input: historical growth; tapered), Terminal P/S: 1.2x / 1.4x / 1.7x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$73.661.01xyesEPS $3.09, growth 24% (input: historical EPS growth), PEG=1.01 (Fair)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAsset$42.911.73xyesBV $20.89 + 5yr PV of (ROE (TTM) 14.8% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$38.101.95xyes√(22.5 × EPS $3.09 × BVPS $20.89) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarnings$46.901.58xyesFCF $634.5M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$99.650.74xyesEPS $3.09 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelative$131.250.57xyesRevenue $5.99B × sector P/S 2.5x
PEG Fair ValueRelative$110.500.67xyesEPS $3.09 × (PEG 1.5 × growth 23.9% (input: historical EPS growth)) → PE 35.8x
Earnings YieldEarnings$33.392.22xyesEPS $3.09 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$1.0b
Net debt / NOPAT (after-tax)2.50x
Net debt / operating income (pre-tax)1.91x
Interest coverage6.5x
Share count CAGR (dilution)0.6%
Burning cashno

Bullet Takeaways

Bull Case

Here is the surprising part. For a stock that has compounded through acquisition for years, the market is asking for very little. The price embeds operating-income growth of only about 4.8% a year, a pace Stantec has been beating handily. Its 2026 guidance calls for adjusted earnings-per-share growth of 15% to 18% and net revenue growth of 8.5% to 11.5%, and first-quarter adjusted EPS rose 14.7%. The priced-in bar sits well below the company's own plan and its recent record. The stretch, such as it is, lies in how long the growth must persist, not in the rate.

The engine that produces this is a disciplined roll-up. Stantec buys regional engineering and design firms, folds them into one platform, and lifts their margins. Adjusted EBITDA margin reached 16.9% in the first quarter, up about 70 basis points from a year earlier, and management targets 17.6% to 18.2% for the full year. Adjusted return on invested capital runs above 13%. The acquisition of Page lifted backlog in the Buildings business by more than 40%. Acquisitions have nudged the share count up only about 0.6% a year, so the growth is not being bought with heavy dilution.

Visibility is unusually good for an industrials name. Contract backlog hit a record 9.0 billion dollars at the end of the first quarter, up 13.2% from a year earlier and worth about thirteen months of work. Water revenue grew 14.3% organically and energy and resources 8.6%, both tied to long-cycle public and private spending. On the valuation, the relative multiple and growth methods land at or above the price, and only the asset-based methods sit below it, which is normal for a people-and-reputation business whose worth is not on the balance sheet.

Bear Case

Engineering and design services move with a cycle, and the cycle has been unusually kind. A record backlog is a snapshot of demand already booked, not a promise about the next one. Much of Stantec's recent organic growth rides public infrastructure spending, water and transportation programs, and private development, all of which bend with government budgets and interest rates. When infrastructure funding plateaus after a stimulus wave, or when higher-for-longer rates slow private projects, backlog conversion and new awards can soften at the same time. The 13.2% backlog growth and mid-single-digit organic pace look strong precisely because the cycle is near a high, which is the wrong moment to extrapolate.

The growth model also has a standing appetite. A roll-up needs a steady supply of firms to buy at sensible prices, and it needs to keep integrating them without breaking the culture that makes an engineering firm productive. Slow the deal flow, or overpay in a competitive market for talent, and reported growth converges toward the organic rate, which is mid-single digits. Profit in a professional-services firm is mostly wages, so a tight labor market for engineers presses on the very EBITDA margin the story depends on. The balance sheet already carries about 1.0 billion dollars of net debt, near 1.9x operating income, from prior deals, so financing the next wave is not free while rates stay elevated.

Then the price. The stock trades at about 18x company-wide operating income, and that already assumes the roughly 4.8% annual operating-income growth continues, which rates as within-range rather than cheap. The asset value methods sit well below the price, so there is little downside cushion from tangible worth. Paying a full multiple at a cyclical high for a business that must keep acquiring to grow leaves a thin margin for error.

Valuation

At $69.51 (July 19, 2026), the price is paying about 18x company-wide operating income, and inverted that embeds operating-income growth of roughly 4.8% a year over a five-year stage. Against Stantec's own record that pace is within-range; the demanding part is the duration, not the rate. The build even leans on an operating margin near 1.6%, below the roughly 9.1% the firm earns today, so it is not a bet on margin expansion. The balance sheet carries about 1.0 billion dollars of net debt, near 1.9x operating income, and operating income covers its interest bill about 6.5x, comfortable for a services firm.

Across the applicable methods the price is justified by the relative multiple and growth reads, while the asset-based ones land below it. The price sits about 0.8x the peer multiple methods and about 0.7x the growth methods, both of which see more value than the tape. It sits about 1.5x the earnings power methods and about 1.7x the asset value methods, which is expected for a firm whose worth is its people and client relationships rather than hard assets. Net, this reads as a growth-and-quality name carried by its earnings and multiple, not a balance-sheet value play.

Catalysts

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Stantec Q1 2026 and 2026 outlook · Stantec 2026 outlook · Stantec Q1 2026 · Stantec reporting cadence

View the full interactive STN report on boothcheck